ARX
"Accelerant grew adjusted EBITDA 149% with a two-sided insurance risk exchange serving 265 MGAs across 22 countries. The 8% take rate and 135% net revenue retention rival best-in-class SaaS metrics. Yet 37% of Q3 EBITDA came from irregular investment gains, the CFO is the only insider selling, and FY2026 EBITDA guidance is flat when stripping those gains. Is this a generational platform play with growing pains, or is the financial reporting masking weaker underlying economics?"
Accelerant Holdings is a Cayman Islands-incorporated, NYSE-listed specialty insurance platform that operates a two-sided risk exchange connecting Managing General Agents (MGAs) with reinsurers, insurance companies, and institutional investors. The company earns approximately 8% of exchange written premium as fees. Recently IPO'd in 2025, Accelerant has grown exchange written premium to over $4 billion annually with 265+ MGA members and 92 risk capital partners. The platform leverages proprietary data analytics across 57,000 unique attributes to improve underwriting outcomes and deliver a gross loss ratio in the low 50s.
Executive Summary
Cross-lens roll-up assessment
Accelerant Holdings operates a genuinely innovative two-sided specialty insurance platform with structurally durable economics. The Exchange Services segment earns an 8% fee on exchange written premium with 70% EBITDA margins, and the 135% net revenue retention demonstrates strong organic growth from existing MGA members. The platform's data analytics capabilities (57,000 unique attributes, AI-driven risk models) create real competitive advantages that translate to industry-leading gross loss ratios in the low 50s. However, the financial reporting is unusually complex for a company of this size. Adjusted EBITDA includes irregular investment gains from owned MGA stakes, deferred ceding commission timing creates cash-earnings gaps, and the deliberate reduction of Underwriting segment revenue makes trend analysis difficult. FY2026 EBITDA guidance of $269M is essentially flat vs. FY2025 ($270M including gains), suggesting underlying growth of approximately 16% once gains are stripped. The CFO being the sole net seller among 10 insiders, combined with potential departure signals, creates a governance overhang. Hadron/Altamont concentration in third-party insurer premium (54%) is declining but remains a counterparty risk.
The platform model is genuinely innovative with durable economics, but the financial reporting complexity, embedded investment gains, and CFO selling pattern require investors to do more work than typical to validate the investment case.
Key Takeaways
- •ACCOUNTING_INTEGRITY is QUESTIONABLE: Multiple non-GAAP layers obscure true profitability. Q3 2025 Adjusted EBITDA of $105M included $39M irregular investment gains (37% of total). $1.38B noncash IPO profit interest charge makes GAAP results largely uninterpretable. Company declines to provide GAAP reconciliation for forward guidance.
- •REVENUE_DURABILITY is CONDITIONAL: The 8% Exchange Services fee and 135% NRR are structurally strong, but only 2 quarters of public data exist. FY2026 EBITDA guidance is flat vs. FY2025 when gains are excluded, creating a disconnect between premium growth (20%+) and earnings growth (16%).
- •FUNDING_FRAGILITY is MODERATE: $547M cash outside underwriting entities provides a strong buffer. However, the model depends on continuous access to third-party risk capital, and the Hadron concentration (54% of third-party premium) creates single-counterparty vulnerability.
- •GOVERNANCE_ALIGNMENT is MIXED: Co-founders retain substantial equity and received fresh RSU grants. CFO Jay Green is the only net seller among all insiders (-229,262 shares), creating an asymmetry that warrants monitoring alongside potential departure signals.
- •REGULATORY_EXPOSURE is MODERATE: Operating across 22 countries with multiple insurance entities creates broad regulatory surface area. Clean litigation record and new Lloyd's facility are positive signals. Regulatory friction can slow third-party insurer transitions.
Key Tensions
- •The platform model generates strong fee-based revenue (8% take rate, 70% EBITDA margin in Exchange Services) but the aggregate financial reporting obscures this with complex multi-segment accounting, investment gains, and deferred recognition timing.
- •Management is deliberately reducing Underwriting segment revenue to improve capital efficiency, but this creates unusual optics where headline revenue growth may decelerate even as the underlying business strengthens.
- •The CFO selling pattern and potential departure coincide with a critical post-IPO period when accounting credibility is being established with public market investors.
Fugazi Filter
Are the numbers trustworthy?
Dual-Axis Risk Classification
Position shows Accounting Integrity × Funding Fragility
No elevated red flags detected. Standard investment analysis practices apply — focus on valuation and business fundamentals.
Key FindingsClick to expand details
Signal AssessmentsClick for full context
| Signal | Scale | Assessment | Evidence |
|---|---|---|---|
Accounting Integrity | — | QUESTIONABLE | 2Corroborated |
Governance Alignment | — | MIXED | 2Corroborated |
Model Debates
Cross-Lens Insights
Where Lenses Agree
- ✓Non-GAAP complexity identified across Fugazi Filter and Gravy Gauge as the dominant analytical challenge
- ✓Platform economics validated by Gravy Gauge and Stress Scanner: 8% take rate, 70% ES margins, 135% NRR
- ✓CFO selling anomaly confirmed by Insider Investigator and Fugazi Filter as a governance watchpoint
- ✓Hadron/Altamont concentration flagged by three lenses (Fugazi Filter, Gravy Gauge, Stress Scanner) as declining but material
Where Lenses Differ
REVENUE_DURABILITY
The platform model generates strong fee-based revenue but the financial reporting obscures it. Business fundamentals may be better than the accounting transparency suggests.
The following publicly available documents were collected and extracted into a structured fact dossier that powered this analysis.
SEC Filing
- Annual Report (10-K) — FY2025
- Quarterly Report (10-Q) — Q3 2025
- Quarterly Report (10-Q) — Q2 2025
- Current Report (8-K) — Q4/FY2025 Earnings (Feb 2026)
- Current Report (8-K) — Q3 2025 Earnings
- Current Report (8-K) — Q2 2025 Earnings
- Form 4 Insider Transaction Filings (20 filings, Jul 2025 - Mar 2026)
Earnings Transcript
- Q3 2025 Earnings Call Transcript
- Q2 2025 Earnings Call Transcript